Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of SYNC-T - Immunotherapy Regimen Given After Controlled Cellular Lysis for Patients With Advanced/Metastatic Solid Tumors

NCT05544240 is registered in ClinicalTrials.gov with Williams Cancer Foundation as lead sponsor.

NCT NCT05544240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05544240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of SYNC-T - Immunotherapy Regimen Given After Controlled Cellular Lysis for Patients With Advanced/Metastatic Solid Tumors
Lead sponsor
Williams Cancer Foundation
Phase
Phase 1
Overall status
Recruiting
Start date
February 1, 2023
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, metastatic breast cancer, metastatic cancer, metastatic lung cancer, solid tumor